|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/16 | |
| A61K 9/16 | |||
| A61K 9/00 | |||
| A61K 31/4422 | |||
| A61K 9/06 |
| (11) | Number of the document | 2672983 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12744708.4 |
| Date of filing the European patent application | 2012-02-13 | |
| (97) | Date of publication of the European application | 2013-12-18 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/024893 |
| Date | 2012-02-13 |
| (87) | Number | WO 2012/109664 |
| Date | 2012-08-16 |
| (30) | Number | Date | Country code |
| 201161441695 P | 2011-02-11 | US |
| (72) |
LEUTHNER, Brian, A., US
MACDONALD, Loch, R., CA
|
| (73) |
Edge Therapeutics, Inc.,
200 Connell Drive Suite 1600, Berkeley Heights, NJ 07922,
US
|
| (54) | COMPOSITIONS AND METHODS FOR IMPROVING PROGNOSIS OF A HUMAN WITH SUBARACHNOID HEMORRHAGE |
| COMPOSITIONS AND METHODS FOR IMPROVING PROGNOSIS OF A HUMAN WITH SUBARACHNOID HEMORRHAGE |